PRDM16 and type 2 diabetes mellitus: Future studies will investigate how to stabilize the PRDM16–EHMT1 complex and activate classical brown adipocytes in adult humans, which may lead to novel therapeutic strategies against obesity and metabolic diseases such as type 2 diabetes.